CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials

2024-9-9

Multifaceted role of the DNA replication protein MCM10 in maintaining genome stability and its implication in human diseases

2024-9-6

Lost at SCLC: a review of potential platinum sensitizers

2024-8-23

Tissue factor pathway inhibitor-2 (TFPI-2)—an underappreciated partaker in cancer and metastasis

2024-8-17

Advances in the molecular biology of the solitary fibrous tumor and potential impact on clinical applications

2024-8-9

Molecular and cellular mechanisms of chemoresistance in paediatric pre–B cell acute lymphoblastic leukaemia

2024-8-5

Failure to progress: breast and prostate cancer cell lines in developing targeted therapies

2024-7-26

Role of MARCH E3 ubiquitin ligases in cancer development

2024-7-22

Correlates of health-related quality of life in African Americans diagnosed with cancer: a review of survivorship studies and the Detroit research on cancer survivors cohort

2024-7-20

Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies

2024-7-15

Striated muscle: an inadequate soil for cancers

2024-7-12

Mechanical deformation and death of circulating tumor cells in the bloodstream

2024-7-9

Functional and clinical roles of stromal PDGF receptors in tumor biology

2024-7-9

Electrical excitability of cancer cells—CELEX model updated

2024-7-8

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

2024-7-5

Cancer treatments as paradoxical catalysts of tumor awakening in the lung

2024-7-4

Racial disparity in prostate cancer: an outlook in genetic and molecular landscape

2024-6-20

The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer

2024-5-27

Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer

2024-5-23

Multiomics approach towards characterization of tumor cell plasticity and its significance in precision and personalized medicine

2024-5-18

Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review

2024-5-16

The roles of PD-L1 in the various stages of tumor metastasis

2024-5-11

Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy

2024-4-11

In vivo manufacture and manipulation of CAR-T cells for better druggability

2024-4-9

The role of circular RNA during the urological cancer metastasis: exploring regulatory mechanisms and potential therapeutic targets

2024-4-1

Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination

2024-3-28

Glioblastoma stem cell metabolism and immunity

2024-3-26

OX40/OX40 ligand and its role in precision immune oncology

2024-3-25

Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance

2024-3-18

The fibro-adipogenic progenitor APOD+DCN+LUM+ cell population in aggressive carcinomas

2024-3-11

TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer

2024-3-7

Survival mechanisms of circulating tumor cells and their implications for cancer treatment

2024-3-4

Epidemiology of nasopharyngeal carcinoma: current insights and future outlook

2024-3-2

Biographies

2024-3-1

Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics

2024-3-1

Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?

2024-3-1

Preface

2024-3-1

Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma

2024-2-27

Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation

2024-2-19

Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance

2024-2-8

Clusterin: a marker and mediator of chemoresistance in colorectal cancer

2024-2-6

Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance

2024-1-22

The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression

2024-1-19

Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy

2024-1-18

Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response

2024-1-16

The emerging roles of histone demethylases in cancers

2024-1-16

Deciphering cellular plasticity in pancreatic cancer for effective treatments

2024-1-9

UCP2 and pancreatic cancer: conscious uncoupling for therapeutic effect

2024-1-9

PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases

2024-1-5

Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals

2024-1-3